The New Palgrave Dictionary of Economics

2018 Edition
| Editors: Macmillan Publishers Ltd

Economic Epidemiology

  • Tomas J. Philipson
Reference work entry
DOI: https://doi.org/10.1057/978-1-349-95189-5_2458

Abstract

The economic analysis of epidemiological issues has different implications for disease and its optimal control from those of traditional analysis of such issues. It views undesirable disease occurrence as the result of self-interested behaviour in the presence of constraints. Unlike with methods used in public health, the effects and desirability of disease-reducing public interventions are then evaluated in terms of how they improve the private behaviour essential to controlling disease. Economic epidemiology has been applied to a wide range of topics, including infectious diseases such as AIDS, and also to non-infectious behaviour such as smoking, obesity, and crime.

Keywords

Economic epidemiology Health subsidy Morbidity Mortality Programme evaluation Public health Rational epidemics 

JEL Classifications

I1 
This is a preview of subscription content, log in to check access.

Bibliography

  1. Ahituv, A., J. Hotz, and T. Philipson. 1996. Is AIDS self-limiting? Evidence on the prevalence elasticity of the demand for condoms. Journal of Human Resources 31: 869–898.CrossRefGoogle Scholar
  2. Auld, M.C. 2003. Choices, beliefs, and infectious disease dynamics. Journal of Health Economics 22: 361–377.CrossRefGoogle Scholar
  3. Auld, M.C. 2006. Estimating behavioral response to the AIDS epidemic. Contributions to Economic Analysis and Policy, 5(1), Article 1.Google Scholar
  4. Barrett, S. 2003. Global disease eradication. Journal of the European Economic Association 1: 591–600.CrossRefGoogle Scholar
  5. Barrett, S., and M. Hoel. 2004. Optimal disease eradication. Working Paper No. 604, FEEM.Google Scholar
  6. Brito, D., E. Sheshinski, and M. Intriligator. 1991. Externalities and compulsory vaccinations. Journal of Public Economics 45: 69–90.CrossRefGoogle Scholar
  7. Cawley, J. 1999. Obesity and addiction. Ph.D. dissertation, Department of Economics, University of Chicago.Google Scholar
  8. Chou, S.Y., M. Grossman, and H. Saffer. 2004. An economic analysis of adult obesity, results from the behavioral risk factor surveillance system. Journal of health Economics 23: 565–587.CrossRefGoogle Scholar
  9. Cutler, D.M., E.L. Glaeser, and J.M. Shapiro. 2003. Why have Americans become more obese? Journal of Economic Perspectives 17(3): 93–118.CrossRefGoogle Scholar
  10. Geoffard, P.Y., and T. Philipson. 1996. Rational epidemics and their public control. International Economic Review 37: 603–624.CrossRefGoogle Scholar
  11. Gersovitz, M., and J.S. Hammer. 2003. Infectious diseases, public policy, and the marriage of economics and epidemiology. The World Bank Research Observer 18: 129–157.CrossRefGoogle Scholar
  12. Gersovitz, M., and J.S. Hammer. 2004. The economical control of infectious diseases. Economic Journal 114: 1–27.CrossRefGoogle Scholar
  13. Gersovitz, M., and J.S. Hammer. 2005. Tax/subsidy policies toward vector-borne infectious diseases. Journal of Public Economics 89: 647–674.CrossRefGoogle Scholar
  14. Grossman, M., and I. Rashad. 2004. The economics of obesity. Public Interest 156: 104–112.Google Scholar
  15. Horowitz, B.J., and B.H. Moehring. 2004. How property rights and patents affect antibiotic resistance. Health Economics 13: 575–583.CrossRefGoogle Scholar
  16. Kremer, M. 1996. Integrating behavioral choice into epidemiological models of the AIDS epidemic. Quarterly Journal of Economics 111: 549–573.CrossRefGoogle Scholar
  17. Lakdawalla, D., T. Philipson, and J. Bhattacharya. 2005. Welfare enhancing technological change and the growth of obesity. American Economic Review 95: 253–258.CrossRefGoogle Scholar
  18. Lakdawalla, D., N. Sood, and D. Goldman. 2006. HIV breakthroughs and risky sexual behavior. Quarterly Journal of Economics 121: 1063–1102.CrossRefGoogle Scholar
  19. Laxminarayan, R. 2002. How broad should the scope of antibiotics patents be? American Journal of Agricultural Economics 84: 1287–1292.CrossRefGoogle Scholar
  20. Laxminarayan, R., and G.M. Brown. 2001. Economics of antibiotics resistance: A theory of optimal use. Journal of Environmental Economics and Management 42: 183–206.CrossRefGoogle Scholar
  21. Laxminarayan, R., and M.L. Weitzman. 2002. On the implications of endogenous resistance to medications. Journal of Health Economics 21: 709–718.CrossRefGoogle Scholar
  22. Malani, A. 2006. Identifying placebo effects with data from clinical trials. Journal of Political Economy 114: 236–256.CrossRefGoogle Scholar
  23. Mechoulan, S. 2004. HIV testing, a Trojan horse? Topics in Economic Analysis and Policy, 4(1), article 18.Google Scholar
  24. Oster, E. 2006. HIV and sexual behavior change: Why not Africa? Working paper, Graduate School of Business, University of Chicago.Google Scholar
  25. Philipson, T. 1995. The welfare loss of disease and the theory of taxation. Journal of Health Economics 14: 387–396.CrossRefGoogle Scholar
  26. Philipson, T. 2000. Economic epidemiology and infectious disease. In Handbook of Health Economics, ed. T. Culyer and J. Newhouse. Amsterdam: North-Holland.Google Scholar
  27. Philipson, T., and J. DeSimone. 1997. Experiments and subject sampling. Biometrika 84: 618–632.CrossRefGoogle Scholar
  28. Philipson, T., and L. Hedges. 1998. Subject evaluation in social experiments. Econometrica 66: 381–409.CrossRefGoogle Scholar
  29. Philipson, T., S. Mechoulan, and A.B.. Jena. 2006. IP and external consumption effects: Generalizations from health care markets. Working Paper No. 11930. Cambridge, MA: NBER.Google Scholar
  30. Philipson, T., and R.A. Posner. 1993. Private choices and public health, an economic interpretation of the AIDS epidemic. Cambridge, MA: Harvard University Press.Google Scholar
  31. Philipson, T., and R.A. Posner. 2003. The long run growth of obesity as a function of technological change. Perspectives in Biology and Medicine 46(3): 87–108.CrossRefGoogle Scholar
  32. Rashad, I., and M. Grossman. 2004. The economics of obesity. Public Interest 156: 104–112.Google Scholar

Copyright information

© Macmillan Publishers Ltd. 2018

Authors and Affiliations

  • Tomas J. Philipson
    • 1
  1. 1.